LivaNova PLC (LIVN)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Vladimir A. Makatsaria | CEO & Director | 2.4M | -- | 1973 |
| Mr. Alex Shvartsburg C.M.A. | Chief Financial Officer | 1.09M | -- | 1970 |
| Mr. Michael D. Hutchinson | Senior VP, Chief Legal Officer & Company Secretary | 995.61k | -- | 1971 |
| Mr. Ahmet Tezel Ph.D. | Chief Innovation Officer | 846.06k | -- | -- |
| Mr. Franco Poletti | President of Cardiopulmonary Business Unit | 1.13M | -- | -- |
| Ms. Lindsey Little | Senior Director of Investor Relations | -- | -- | -- |
| Deanna Wilke | Vice President of Corporate Communications | -- | -- | -- |
| Mr. Philip Kowalczyk | Chief Strategy & Corporate Development Officer | -- | -- | -- |
| Ms. Natalia Kozmina | Chief Human Resources Officer | -- | -- | -- |
| Mr. Paul R. Buckman | President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement | -- | -- | 1956 |
LivaNova PLC
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 2,900
Description
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Corporate Governance
Upcoming Events
July 29, 2025 at 12:30 PM UTC - August 4, 2025 at 12:30 PM UTC
LivaNova PLC Earnings Date
Recent Events
May 7, 2025 at 12:00 AM UTC
IRANNOTICE: Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
February 25, 2025 at 12:00 AM UTC
IRANNOTICE: Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
August 1, 2024 at 12:00 AM UTC
IRANNOTICE: Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act